Bedrijfssegmenten Laboratorios Richmond S.A.C.I.F.
Aandelen
RICH
ARLRIC300027
Farmaceutische producten
|
Slotkoers
Buenos Aires S.E.
14-08-2026
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 1.555,00 ARS | +0,32% |
|
+1,30% | -21,27% |
Omzet van 2025 per bedrijfssegment
Omzet van 2025 per geografisch gebied
Historisch overzicht van de omzetverdeling per activiteitensegment
Nettowinst: Verdeling van de bedrijfssegmenten
| Start boekjaar: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Private Market | 5,91 mld. | 11,99 mld. | 32,64 mld. | 78,28 mld. | 101 mld. | |||||
Brutowinst | 3,28 mld. | 6,23 mld. | 18,49 mld. | 44,3 mld. | 65,66 mld. | |||||
Nettowinst | 290 mln. | 183 mln. | -5,27 mld. | 13,42 mld. | 8,83 mld. | |||||
Public Market - Others | 3,02 mld. | 3,12 mld. | 4,97 mld. | 9,88 mld. | 19,62 mld. | |||||
Brutowinst | 1,06 mld. | 1,33 mld. | 1,77 mld. | 3,89 mld. | 8,91 mld. | |||||
Nettowinst | 141 mln. | 59,41 mln. | -2,11 mld. | 907 mln. | 881 mln. | |||||
Foreign Trade | 458 mln. | 692 mln. | 1,42 mld. | 3,63 mld. | 6,22 mld. | |||||
Brutowinst | 210 mln. | 351 mln. | 295 mln. | 1,83 mld. | 3,62 mld. | |||||
Nettowinst | 8,49 mln. | -197 mln. | -583 mln. | 169 mln. | 1,01 mld. | |||||
Public Market - Vaccines | 7,22 mld. | 2,67 mld. | - | - | - | |||||
Brutowinst | 381 mln. | 817 mln. | - | - | - | |||||
Nettowinst | -8,94 mln. | -39,12 mln. | - | - | - | |||||
Nettowinst | 160 mln. | 156 mln. | -2,89 mld. | 9,35 mld. | -7,56 mld. | |||||
Nettowinst | - | - | - | - | -80,43 mln. | |||||
Public Market | - | - | - | - | - | |||||
Brutowinst | - | - | - | - | - | |||||
Nettowinst | - | - | - | - | - | |||||
Pharmaceutical Products | ||||||||||
Pharmaceuticals | - | - | - | - | - | |||||
Rente kosten | - | - | - | - | - | |||||
Inkomstenbelastingkosten | - | - | - | - | - | |||||
Totaal activa | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Resultaat voor belastingen | - | - | - | - | - | |||||
Brutowinst | - | - | - | - | - | |||||
Bedrijfssegmenten - afschrijvingen en waardeverminderingen | - | - | - | - | - | |||||
Nettowinst | - | - | - | - | - |
Historische geografische spreiding van de omzet
| Start boekjaar: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Argentina | 15,6 mld. | 18,64 mld. | 40,15 mld. | 92,98 mld. | 127 mld. | |||||
Foreign | 662 mln. | 624 mln. | 1,26 mld. | 3,28 mld. | 5,56 mld. | |||||
Unallocated Refund for Exports | - | - | - | - | - | |||||
Unallocated Granted Discounts | - | - | - | - | - | |||||
Unallocated Bonuses and Returns | - | - | - | - | - | |||||
Unallocated Gross Income Tax | - | - | - | - | - | |||||
Unallocated | -401 mln. | -790 mln. | -2,38 mld. | -4,46 mld. | -5,81 mld. |
- Beurs
- Aandelen
- Koers RICH
- Financiën Laboratorios Richmond S.A.C.I.F.
- Bedrijfssegmenten
Kies jouw editie
Alle financiële informatie op nationaal niveau
